Methodology

All entries for: Mustang Bio Inc.

July 1, 2025

Mustang Bio Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of malignant glioma

Disease Area: Rare Diseases
Source
Source
Scroll to Top